SHANGHAI JUNSHI BIO YC1 Net Asset Momentum
SHANGHAI JUNSHI BIO YC1 net asset momentum. SHANGHAI JUNSHI BIO YC1 (8SJ) recorded a net asset momentum of 2.1% as of December 2025, with net assets of €6.07 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore 8SJ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of SHANGHAI JUNSHI BIO YC1 (2021–2025)
Net asset momentum of SHANGHAI JUNSHI BIO YC1 from 2021 to 2025. This chart tracks SHANGHAI JUNSHI BIO YC1's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +2.1%, with net assets of €6.07 Billion EUR as of December 2025. See SHANGHAI JUNSHI BIO YC1 (8SJ) shareholders funds for net asset value and shareholders' equity analysis.
SHANGHAI JUNSHI BIO YC1 Net Asset Momentum by Year (2021–2025)
SHANGHAI JUNSHI BIO YC1 net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for SHANGHAI JUNSHI BIO YC1 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see SHANGHAI JUNSHI BIO YC1 (8SJ) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €6.07 Billion | €12.40 Billion | €6.33 Billion | ▲ +2.1% |
| 2024 | €5.95 Billion | €10.80 Billion | €4.85 Billion | ▼ -18.9% |
| 2023 | €7.34 Billion | €11.36 Billion | €4.02 Billion | ▼ -25.1% |
| 2022 | €9.79 Billion | €12.58 Billion | €2.78 Billion | ▲ +17.5% |
| 2021 | €8.33 Billion | €11.05 Billion | €2.72 Billion | — |